Old Web
English
Sign In
Acemap
>
authorDetail
>
Jason Silversteen
Jason Silversteen
Christiana Care Health System
Clinical Practice
Expanded Disability Status Scale
Fingolimod
Multiple sclerosis
Disease
3
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study
2018
Current Medical Research and Opinion
Robert Zivadinov
Nasreen Khan
Jonathan R. Korn
Ellen S. Lathi
Jason Silversteen
Jonathan Calkwood
Scott Kolodny
Diego Silva
Jennie Medin
Bianca Weinstock Guttman
Show All
Source
Cite
Save
Citations (5)
Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study.
2018
CNS Drugs
Bianca Weinstock Guttman
Jennie Medin
Nasreen Khan
Jonathan R. Korn
Ellen S. Lathi
Jason Silversteen
Jonathan Calkwood
Diego Silva
Robert Zivadinov
Show All
Source
Cite
Save
Citations (23)
Assessing no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis receiving fingolimod: results from a longitudinal, multicenter, real-world study (P4.388)
2017
Neurology
Bianca Weinstock-Guttman
Jennie Medin
Nasreen Khan
Jonathan R. Korn
Jenny Price
Diego Silva
Ellen S. Lathi
Jason Silversteen
Keith Edwards
Robert Zivadinov
Show All
Source
Cite
Save
Citations (0)
1